dHACM - MiMedx

Drug Profile

dHACM - MiMedx

Alternative Names: AmnioFix®; Amniotic cell therapy - MiMedix; Dehydrated human amnion/chorion allograft; Dehydrated human amnion/chorion membrane; Dehydrated human amniotic membrane; Dehydrated human amniotic membrane micronised; Human amniotic membrane allograft - MiMedix; Micronised dehydrated human amniotic membrane; Micronised tissue allografts - MiMedx; Micronized dHACM

Latest Information Update: 03 Apr 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator MiMedx
  • Class Anti-inflammatories; Cell therapies; Foot disorder therapies; Tissue extracts
  • Mechanism of Action Cell replacements; Cell stimulants; Tissue replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Plantar fasciitis; Tendinitis
  • Phase II Osteoarthritis; Wounds
  • Clinical Phase Unknown Shoulder injuries
  • Preclinical Ischaemia

Most Recent Events

  • 28 Mar 2018 MiMedx plans a phase IIb trial for Osteoarthritis (In adults, In the elderly) in USA in the first quarter of 2018
  • 28 Mar 2018 Phase-II clinical trials in Osteoarthritis (In adults, In the elderly) in USA (Injection) (NCT03485157)
  • 26 Mar 2018 Safety and efficacy data from a phase IIb trial in Plantar fasciitis released by MiMedx
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top